Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging

Author： Stępień Ewa   Kabłak-Ziembicka Anna   Czyż Jarosław   Przewłocki Tadeusz   Małecki Maciej  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.7, 2012-07, pp. : 677-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Vascular Aging: A New Target for Hypertension Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 1, 2016-01 ,pp. : 122-126

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of anti-oxidants and diabetic retinopathy

By Kowluru Renu A   Kennedy Alexander  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1665-1676

Informa Healthcare

Access to resources Recommend Favorite

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 511-524

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin and Bradykinin: Targets for the Treatment of Vascular and Neuro-Glial Pathology in Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3313-3330

Bentham Science Publishers

Access to resources Recommend Favorite